Journey Medical Corporation
DERM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $18 | $15 | $13 | $14 |
| % Growth | 17.5% | 14.2% | -3.5% | – |
| Cost of Goods Sold | $6 | $6 | $5 | $2 |
| Gross Profit | $12 | $9 | $8 | $11 |
| % Margin | 67.4% | 60% | 63.5% | 83.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $12 | $11 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $13 | $0 | $1 | -$1 |
| Operating Expenses | $13 | $12 | $12 | $9 |
| Operating Income | -$2 | -$3 | -$3 | $2 |
| % Margin | -8.7% | -19.2% | -25.3% | 16.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$2 | -$4 | -$4 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$4 | -$4 | $2 |
| % Margin | -13.1% | -25.3% | -31% | 11.2% |
| EPS | -0.09 | -0.16 | -0.18 | 0.069 |
| % Growth | 43.8% | 11.1% | -362% | – |
| EPS Diluted | -0.09 | -0.16 | -0.18 | 0.069 |
| Weighted Avg Shares Out | 25 | 23 | 23 | 22 |
| Weighted Avg Shares Out Dil | 25 | 23 | 23 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$0 | -$2 | -$2 | $3 |
| % Margin | -1.8% | -11.4% | -16% | 25.1% |